Home health Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback

Sanofi Toronto

A COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them to move to a late-stage study, the companies announced on Monday.



from CBC | Health News https://ift.tt/3wb19Ip
Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback Reviewed by mr anox on 08:39 Rating: 5

Aucun commentaire:

Inscription à : Publier les commentaires ( Atom )
Fourni par Blogger.